Key Highlights

  • Horizon Technology Finance (HRZN) yields about 15.69%, paying monthly; the next ex-dividend date is Oct. 16.
  • The monthly Dividend was reset lower in 2026 to better match earnings, and it still exceeds reported earnings.
  • HRZN is down 30.7% year-to-date and trades below its 20-day, 50-day and 200-day moving averages.

Horizon Technology Finance (NASDAQ:HRZN) rose 0.4% to $4.61 in pre-market trading with no company news, but the venture Debt lender is down 30.7% this year after resetting its monthly dividend. The stock yields about 15.7% and trades at roughly 0.74 times book value, a discount that shows investors are skeptical about Credit quality in the startup lending market.

Horizon's dividend Yield has climbed to about 15.7 percent. Horizon is a Business Development Company that makes secured venture loans to technology, life sciences and healthcare startups backed by Venture Capital firms. The appeal is monthly income, a favorite of retirees, but the yield has climbed partly because the stock has fallen.

Horizon reset its monthly payout this year, and its dividend currently exceeds earnings, a warning sign for coverage. The company is still finding deals: its RoHo joint venture recently provided a Loan Facility of up to $30 million to NeoVolta, and Compass Point started coverage at Buy. Book Value was about $6.23 per share.

Horizon Technology Finance (HRZN) Edges Higher on Light Volume

The $0.02 move equaled about 0.1x the 14-day average true range of $0.13, and only about $1.64 million traded versus a typical $3.16 million. HRZN traded between $4.56 and $4.63. The stock is down 5.6% over the past month, and its 52-week range is $3.80 to $6.85. The market Capitalization is roughly $230 million to $308 million.

HRZN Technical Levels: Below the Averages

HRZN trades below its 20-day Moving Average of $4.73, its 50-day of $4.69 and its 200-day of $5.07. Moving averages show the trend, and a price below all three means sellers control every time frame.

The 14-day RSI is 43.3. RSI measures buying versus selling pressure on a 0 to 100 scale, and a reading in the low 40s is soft but not oversold.

Reclaiming the 20-day average near $4.73 would be the first sign of stabilization.

Analyst View

Analysts rate HRZN Hold with an average target near $5.08, about 10% above the current price. Short interest is about 4.2%.